Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Buters

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|November 1, 1995
Normal p53 status and function despite the development of drug resistance in human breast cancer cellsK Wosikowski, J T Regis, R W Robey, et al.
Toxicology and Applied Pharmacology|October 17, 1998
Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null miceH Zaher, J T Buters, J M Ward, et al.
Biochemical Pharmacology|November 27, 1995
Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4H V Gelboin, K W Krausz, I Goldfarb, et al.
Molecular Carcinogenesis|December 1, 1996
Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthraceneM Shou, K R Korzekwa, K W Krausz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomasJ T Buters, S Sakai, T Richter, et al.
Cancer Research|July 26, 2000
Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthraceneS M Heidel, P S MacWilliams, W M Baird, et al.
Pharmacogenetics|August 1, 1995
Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374C L Crespi, D T Steimel, B W Penman, et al.
Drug Metabolism Reviews|May 21, 1999
Molecular studies on the toxifying effects by genetically engineered cytochromes P450J Doehmer, J T Buters, A Luch, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|November 1, 1995
Normal p53 status and function despite the development of drug resistance in human breast cancer cellsK Wosikowski, J T Regis, R W Robey, et al.
Toxicology and Applied Pharmacology|October 17, 1998
Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null miceH Zaher, J T Buters, J M Ward, et al.
Biochemical Pharmacology|November 27, 1995
Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4H V Gelboin, K W Krausz, I Goldfarb, et al.
Molecular Carcinogenesis|December 1, 1996
Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthraceneM Shou, K R Korzekwa, K W Krausz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomasJ T Buters, S Sakai, T Richter, et al.
Cancer Research|July 26, 2000
Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthraceneS M Heidel, P S MacWilliams, W M Baird, et al.
Pharmacogenetics|August 1, 1995
Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374C L Crespi, D T Steimel, B W Penman, et al.
Drug Metabolism Reviews|May 21, 1999
Molecular studies on the toxifying effects by genetically engineered cytochromes P450J Doehmer, J T Buters, A Luch, et al.
Pageof 3